Your browser doesn't support javascript.
loading
Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions.
Moon, D H; Lee, J-M; Noonan, A M; Annunziata, C M; Minasian, L; Houston, N; Hays, J L; Kohn, E C.
Affiliation
  • Moon DH; Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Br J Cancer ; 109(4): 1072-8, 2013 Aug 20.
Article in En | MEDLINE | ID: mdl-23867999
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Carboplatin / Genes, BRCA1 / Genes, BRCA2 / Drug Hypersensitivity / Antineoplastic Agents Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2013 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Carboplatin / Genes, BRCA1 / Genes, BRCA2 / Drug Hypersensitivity / Antineoplastic Agents Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Br J Cancer Year: 2013 Document type: Article Affiliation country: